×
返回 Agendas
Session Chair(s)
Tatsuo Kagimura, MPH
Chief, Department of Analysis
Translational Research Informatics Center (TRI), Japan
Speaker(s)
Pharmacovigilance in RMP and Pharmacovigilance in Post Approval Re-Examination System
Mamoru Narukawa, PhD, RPh
Kitasato University, Japan
Professor
Why? What is the root cause of current PharmacoVigilance systems in Japan?
Kotonari Aoki, MS
Chugai Pharmaceutical Co., Ltd., Japan
Head of Real World Data Science Dept. Drug Safety Div.
The transition of Pharmacovigilance in JAPAN
Akiko Ogata
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Division Director